The core risk is capture, not existence. MACOM is likely to stay relevant, but if
dual-sourcing rises, supply-chain steps slip, or AI optical demand digests after the current buildout, revenue can still grow while margins and valuation disappoint. The premium starting valuation means execution has to stay unusually clean.